Patent details

EP2650007 Title: Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases

Basic Information

Publication number:
EP2650007
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP130027923
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases
French Title of Invention:
Utilisation d'inhibiteurs de peptidiques perméables aux cellules de la voie de transduction de signal JNK pour le traitement de diverses maladies auto-immunes
German Title of Invention:
Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Autoimmunerkrankungen
SPC Number:

Dates

Filing date:
02/06/2009
Grant date:
20/05/2015
EP Publication Date:
20/05/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2013
EP B1 Publication Date:
20/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/06/2017
Expiration date:
02/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/06/2009
 
 

Name:
Xigen Inflammation Ltd.
Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/06/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Bonny Christophe
Address:
Switzerland (CH)

Priority

Priority Number:
8/004341
Priority Date:
30/05/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 38/01;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/06/2016
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
PAVIS GMBH
Filing date Document type Number of pages